Screening for gestational diabetes mellitus in adolescent Hispanics.

Prim Care Update Ob Gyns

Department of Obstetrics and Gynecology, Medical College of Wisconsin, Wisconsin, Milwaukee, USA

Published: July 1998

AI Article Synopsis

  • The study focused on understanding the rate of gestational diabetes mellitus (GDM) among adolescent Hispanic women and the costs involved in screening.
  • A total of 326 women were screened, and 30 tested positive, leading to five confirmed cases of GDM, resulting in a 1.5% incidence rate.
  • The findings suggest that universal screening for GDM in this demographic may not be necessary due to the low incidence and high costs associated with diagnosing each case.

Article Abstract

Objective: To determine the incidence of gestational diabetes mellitus in an adolescent Hispanic population and calculate the cost of screening.Methods: A retrospective chart review of deliveries to adolescent (<20 years old) Hispanic women from January 1991 through May 1996 was performed. The incidence of gestational diabetes mellitus (GDM) was determined and the cost of screening calculated.Results: Three hundred twenty-six adolescent Hispanic women were screened for GDM with a 1-hour 50-g oral glucose tolerance test at an average gestational age of 26 weeks (range 11-39 weeks), at a cost of $26 per test. Thirty (9.2%) had positive screens defined as a plasma glucose level of >/=140 mg%. Three-hour 100-g oral glucose tolerance tests were performed on those with positive screens, at a cost of $124 per test. Five women were diagnosed with GDM, an incidence of 1.5%. The cost to diagnose each case of GDM was $2,569.Conclusion: The incidence of GDM in this population is low, and therefore universal screening of Hispanic adolescents may be unwarranted and cost prohibitive. Large prospective trials evaluating maternal and neonatal outcomes would provide the best means to assess the value of screening.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1068-607x(98)00113-9DOI Listing

Publication Analysis

Top Keywords

gestational diabetes
8
diabetes mellitus
8
mellitus adolescent
8
screening gestational
4
adolescent hispanics
4
hispanics objective
4
objective determine
4
determine incidence
4
incidence gestational
4
adolescent hispanic
4

Similar Publications

Approach to the Patient using Diabetes Technology in Pregnancy.

J Clin Endocrinol Metab

January 2025

Section of Maternal Fetal Medicine, Obstetrics and Gynecology, University of Chicago.

Diabetes in pregnancy increases risk for complications for the pregnant patient and neonate. Tight glycemic control to maintain glucose levels as close to non-diabetic ranges as possible can lower risk for these complications. Achieving strict glycemic targets can be challenging and technologies including continuous glucose monitors (CGM) and hybrid closed loop (HCL) insulin pumps have the potential to improve diabetes control and pregnancy outcomes.

View Article and Find Full Text PDF

A Life-Course Approach to Gestational Exposure to Famine and Risk of Mortality.

Paediatr Perinat Epidemiol

January 2025

Division of Research, Kaiser Permanente Northern California, Pleasanton, California, USA.

View Article and Find Full Text PDF

Vaginal versus caesarean delivery in fetal macrosomia-a retrospective cohort study.

Wien Med Wochenschr

January 2025

University Department of Gynecology and Obstetrics Clinical Hospital Merkur Zagreb, School of Medicine Catholic University of Croatia Zagreb, Collegium of the Surgical Medical Sciences Croatian Academy of Medical Sciences, Ilica 242, 10 000, Zagreb, Croatia.

Objective: The aims of this study were to determine the incidence of macrosomic births over a 5-year period and to examine the childbirth complications for both mother and newborn.

Patients And Methods: During the study period there were a total of 16,126 deliveries, of which 1905 were macrosomic fetuses (defined as those with a birthweight of 4000 g or more). Data on the course of pregnancy and childbirth were collected from existing maternal and peripartum medical records.

View Article and Find Full Text PDF

Introduction: Diabetes Mellitus (DM) affects both the mother and fetus during and after pregnancy. Multiple studies have shown the prognostic impact of DM on maternal and fetal outcomes, but studies at the national level are limited. Therefore, we aimed to conduct this nationwide study.

View Article and Find Full Text PDF

Background And Objectives: Aside from congenital malformations and impaired postnatal neurodevelopment, risks associated with antiseizure medication (ASM) use during pregnancy have been sparsely investigated, particularly outside of epilepsy. We aimed to assess these risks through a systematic literature review and meta-analysis, including ASM exposure for indication.

Methods: We searched MEDLINE, EMBASE, and Cochrane for studies including pregnant women on ASMs for any indication and untreated pregnant women, investigating obstetric complications and fetal/neonatal complications other than congenital malformations and impaired neurodevelopment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!